Recently, findings in breast cancer have implied that CPT1C, also a PPARα target gene, functions to regulate the senescence phenotype of breast cancer cells and that this regulatory relationship is not directly related to the presence or absence of P53 [114]. This evidence concerns the gene TP53 and breast carcinoma.